We also observed that the median time to onset of GLP-1 RAs-associated acute pancreatitis was 92 (range: 03,312) days across ICSRs that provided both drug initiation and AP onset times, and 2.5 months of the case series, indicating a longer onset duration compared to other gastrointestinal adverse events triggered by GLP-1 RAs (Zhou et al., 2022)
What happens if they stop
42 A follow-up study is underway to evaluate the effects of 3 months of (in)GSH on PD symptom status and MRS GSH concentrations
The FDA does not verify their safety, quality, or effectiveness
Subsequent secondary-source reviews have proposed candidate interactions modulation of GABAergic and glutamatergic tone, possible NMDA-receptor involvement, peripheral 1-adrenergic effects but these have not been replicated in primary studies that establish direct binding or saturable transduction at a defined receptor
These reports come via self experimentation